Investigation of a potential protective mechanism against heparin-induced thrombocytopenia in patients on chronic intermittent hemodialysis

Thrombosis Research

Volumn 131, Issue 3, 2013, Pages 244-248

  Tanhehco, Yvette C ^a   Cuker, Adam ^b,c   Rudnick, Michael ^c   Sachais, Bruce S ^b  

^a Department of Medicine   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Hemodialysis; Heparin; HIT; Mechanism; PF4; Platelet

Indexed keywords

HEPARIN; PADGEM PROTEIN; THROMBOCYTE FACTOR 4;

ADULT; ANTIGEN ANTIBODY COMPLEX; ARTICLE; ARTIFICIAL KIDNEY; BIOASSAY; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEMODIALYSIS; HEPARIN INDUCED THROMBOCYTOPENIA; HUMAN; MALE; PRIORITY JOURNAL; SEROTONIN RELEASE; THROMBOCYTE;

AGED; BLOOD PLATELETS; FEMALE; HEPARIN; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MEMBRANES, ARTIFICIAL; MIDDLE AGED; P-SELECTIN; PLATELET ACTIVATION; PLATELET FACTOR 4; RENAL DIALYSIS; SEROTONIN; SURFACE PROPERTIES; THROMBOCYTOPENIA;

EID: 84875243876     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2012.12.010     Document Type: Article

References (20)

1. L. Rauova, M. Poncz, S.E. McKenzie, M.P. Reilly, G. Arepally, and J.W. Weisel Ultralarge complexes of PF4 and heparin are central to the pathogenesis of heparin-induced thrombocytopenia Blood 105 2005 131 138
2. P. Horsewood, T.E. Warkentin, C.P. Hayward, and J.G. Kelton The epitope specificity of heparin-induced thrombocytopenia Br J Haematol 95 1996 161 167
3. A. Greinacher, S. Alban, V. Dummel, G. Franz, and C. Mueller-Eckhardt Characterization of the structural requirements for a carbohydrate based anticoagulant with a reduced risk of inducing the immunological type of heparin-associated thrombocytopenia Thromb Haemost 74 1995 886 892
4. B.S. Sachais, A.H. Rux, D.B. Cines, S.V. Yarovoi, L.I. Garner, and S.P. Watson Rational design and characterization of platelet factor 4 antagonists for the study of heparin-induced thrombocytopenia Blood 119 25 2012 5955 5962
5. E. Brandt, F. Petersen, A. Ludwig, J.E. Ehlert, L. Bock, and H.D. Flad The beta-thromboglobulins and platelet factor 4: blood platelet-derived CXC chemokines with divergent roles in early neutrophil regulation J Leukoc Biol 67 2000 471 478
6. B. Kasper, and F. Petersen Molecular pathways of platelet factor 4/CXCL4 signaling Eur J Cell Biol 90 2011 521 526
7. P.G. Kerr, and L. Huang Review: membranes for haemodialysis Nephrology (Carlton) 15 2010 381 385
8. R.A. Ward Do clinical outcomes in chronic hemodialysis depend on the choice of a dialyzer? Semin Dial 24 2011 65 71
9. G. Luzzatto, M. Bertoli, G. Cella, F. Fabris, B. Zaia, and A. Girolami Platelet count, anti-heparin/platelet factor 4 antibodies and tissue factor pathway inhibitor plasma antigen level in chronic dialysis Thromb Res 89 1998 115 122
10. S. Yamamoto, M. Koide, M. Matsuo, S. Suzuki, M. Ohtaka, and S. Saika Heparin-induced thrombocytopenia in hemodialysis patients Am J Kidney Dis 28 1996 82 85
11. T. Matsuo, H. Kobayashi, M. Matsuo, K. Wanaka, H. Nakamoto, and H. Matsushima Frequency of anti-heparin-PF4 complex antibodies (HIT antibodies) in uremic patients on chronic intermittent hemodialysis Pathophysiol Haemost Thromb 35 2006 445 450
12. S.I. O'Shea, J.J. Sands, S.A. Nudo, and T.L. Ortel Frequency of anti-heparin-platelet factor 4 antibodies in hemodialysis patients and correlation with recurrent vascular access thrombosis Am J Hematol 69 2002 72 73
13. Y.C. Tanhehco, A.H. Rux, and B.S. Sachais Low-density lipoprotein apheresis reduces platelet factor 4 on the surface of platelets: a possible protective mechanism against heparin-induced thrombocytopenia and thrombosis Transfusion 51 2011 1022 1029
14. R.J. Hirschman, and N.R. Shulman The use of platelet serotonin release as a sensitive method for detecting anti-platelet antibodies and a plasma anti-platelet factor in patients with idiopathic thrombocytopenic purpura Br J Haematol 24 1973 793 802
15. D.M. Boon, H.H. van Vliet, R. Zietse, and M.C. Kappers-Klunne The presence of antibodies against a PF4-heparin complex in patients on haemodialysis Thromb Haemost 76 1996 480
16. M. Carrier, G.A. Knoll, M.J. Kovacs, J.C. Moore, D. Fergusson, and M.A. Rodger The prevalence of antibodies to the platelet factor 4 -heparin complex and association with access thrombosis in patients on chronic hemodialysis Thromb Res 120 2007 215 220
17. A. Greinacher, S. Zinn, Wizemann, and U.W. Birk Heparin-induced antibodies as a risk factor for thromboembolism and haemorrhage in patients undergoing chronic haemodialysis Lancet 348 1996 764
18. T. Sitter, M. Spannagl, B. Banas, and H. Schiffl Prevalence of heparin-induced PF4-heparin antibodies in hemodialysis patients Nephron 79 1998 245 246
19. N. Lubenow, P. Hinz, S. Thomaschewski, T. Lietz, M. Vogler, and A. Ladwig The severity of trauma determines the immune response to PF4/heparin and the frequency of heparin-induced thrombocytopenia Blood 115 2010 1797 1803
20. A. Thijs, M.P. Grooteman, S. Zweegman, M.J. Nube, P.C. Huijgens, and C.D. Stehouwer Platelet activation during haemodialysis: comparison of cuprammonium rayon and polysulfone membranes Blood Purif 25 2007 389 394